gvtcx

PHE_Scientific_ Provision of NucleoCounter

Public Health England Published 30 Mar 2021 Contracts Finder

key details

Value£50,000
Statuscomplete
Category (CPV) 38000000
RegionNorth East
Deadline1 Apr 2020
Contract start2 Apr 2020
Contract end31 Mar 2021
Proceduredirect
SME suitableYes
OCIDocds-b5fd17-a4d852d1-9d22-4e3f-9da2-f0a50ff872e1

Award

SupplierValueDateStatus
Chemometec A/S £50,000 1 Apr 2020 active

description

As part of PHE's response to the ongoing international outbreak of a novel Corona Virus (SARS-CoV-2) Public Health England awarded a contract to Chemometec A/S for the provision of Nucleocounter as part of vitro/in vivo antiviral efficacy studies.

Additional information:

PHE and its successor bodies, discharges its duties as a Category 1 Responder to emergencies on behalf of the Secretary of State for Health within the scope of the Civil Contingencies Act 2004 (CCA 2004). This urgent requirement is in response to the recent COVID -19 outbreak.

PO terms and conditions were used and the attached is an example PO.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
30 Mar 2021 Award update (awardUpdate) · 28179b26-591c-418f-9c47-ed135e18a09b-424802

more from Public Health England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.